Oxcarbazepine: Difference between revisions
Jump to navigation
Jump to search
NCLEX nursing pharmacology monographs — batch import |
Add medication infobox (Drugbox) to monographs |
||
| Line 1: | Line 1: | ||
{{Drugbox | |||
| name = Oxcarbazepine | |||
| brand = Trileptal | |||
| therapeutic = Anticonvulsant | |||
| pharmacologic = Sodium channel blocker (carbamazepine analog) | |||
| onset = Effect over days. | |||
| halflife = Active metabolite half-life about 9 hours; level not routine. | |||
| routes = PO (oral) | |||
| highalert = No | |||
| blackbox = None | |||
| antidote = None. | |||
| pregnancy = Use only if essential. | |||
}} | |||
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | <div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | ||
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ||
Latest revision as of 16:09, 17 June 2026
| Drug monograph · NCLEX study reference | |
| Trade names | Trileptal |
|---|---|
| Therapeutic class | Anticonvulsant |
| Pharmacologic class | Sodium channel blocker (carbamazepine analog) |
| Onset / peak / duration | Effect over days. |
| Half-life / level | Active metabolite half-life about 9 hours; level not routine. |
| Routes | PO (oral) |
| High-alert (ISMP) | No |
| Black box warning | None |
| Antidote / reversal | None. |
| Pregnancy / lactation | Use only if essential. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Oxcarbazepine (brand name Trileptal) — Anticonvulsant; Sodium channel blocker (carbamazepine analog).
Identification
- Therapeutic class: Anticonvulsant.
- Pharmacologic class: Sodium channel blocker (carbamazepine analog).
Pharmacology
- Mechanism of action: Blocks sodium channels with fewer autoinduction effects than carbamazepine.
- Onset / peak / duration: Effect over days.
- Half-life / therapeutic level: Active metabolite half-life about 9 hours; level not routine.
Clinical use
- Indications: Focal seizures.
- Usual dose, route, frequency: Titrated PO twice daily; liquid available.
- Maximum dose / adjustments: Reduce in renal impairment.
Safety
- Contraindications: Hypersensitivity to oxcarbazepine.
- Black box warning: None.
- Interactions: Oral contraceptives (reduced), other antiepileptics.
- Pregnancy / lactation: Use only if essential.
- High-alert: No.
Adverse effects
- Common side effects: Dizziness, somnolence, nausea, diplopia.
- Serious effects to report: Hyponatremia, serious rash, HLA-B*1502-associated reactions.
- Antidote / reversal: None.
Nursing process
- Assessment before administration: Sodium, seizure baseline.
- Interventions during therapy: Monitor sodium, especially in elderly.
- Monitor: Sodium, seizure frequency.
- Evaluation / expected outcome: Seizure control.
Patient teaching
- Patient teaching: Report rash; backup contraception.
- Notify provider if: Rash, confusion, severe headache.
- Administration tips: With or without food.